The groundbreaking treatment of the medication represents a exciting breakthrough in the management of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets dual pathways – GLP-1 and the GIP https://tirzepatide-peptide739220.anchor-blog.com/22416416/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment